Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Who We Are
    3. Media
    4. Nixon Peabody secures more than $49 million in damages and pre-judgement interest for Millennium Pharmaceuticals, Inc., in Delaware Chancery CourtMedia

    Nixon Peabody secures more than $49 million in damages and pre-judgement interest for Millennium Pharmaceuticals, Inc., in Delaware Chancery Court

    May 6, 2021

    Share

    Chicago, IL. Nixon Peabody secured $38.2 million in damages for Millennium Pharmaceuticals, Inc.—a subsidiary of Takeda Pharmaceutical Company—in its fraud claim against Harpoon Therapeutics, Inc., in Delaware Chancery Court. With prejudgment interest (dating back to January 2017), the court’s decision resulted in more than $49 million due to Millennium.

    Nixon Peabody was retained in Spring 2019 in advance of an expedited September 2019 liability trial that ruled in Millennium’s favor on its fraud claim. In a little more than six months, Nixon Peabody prepared for trial involving a cutting-edge technology—the use of conditionally active T-cell therapies for potential cancer cures. In April 2020, the court ruled on liability, finding that Nixon Peabody proved fraud even though the contract was not breached. The court then set a damages hearing in September 2020.

    Nixon Peabody tried the damages component remotely from its Chicago office. Harpoon disputed the fact of damages. The court concluded “there is no doubt” that Millennium satisfied this element. Harpoon also disputed the amount of damages (arguing there were none) and, alternatively, that the damages were no more than $400,000 to $1.7 million due to the uncertainty of future commercialization in this developing field of conditionally active T-cell treatments for cancer.

    The court rejected Harpoon’s arguments and found that Millennium’s damages were significant. In the court’s words, “Millennium did not receive all that it reasonably expected from its investment.” In response to Harpoon’s alternative arguments, the court noted that any “uncertainty cannot be used to benefit a fraudster.”

    “Congratulations to Millennium and our team of litigators, as this was a hard-fought and well-earned victory,” said Ethan Trull and John Ruskusky, partners in Nixon Peabody’s Complex Commercial Disputes practice who led the damages trial team that advised Millennium. “Despite the adjustments of trying this case remotely, our team persevered, going to great lengths to do what was needed to secure the outcome our clients deserve.”

    Nixon Peabody’s team also included Complex Commercial Disputes partner Lisa Sullivan, associate Katie Burnett, e-discovery specialist Anders van Marter, and paralegal Donna Long.

    Nixon Peabody Intellectual Property partner Mark FitzGerald, Complex Commercial Disputes associate Tarae Howell, and patent specialist Angela Hafner also played integral roles in the initial fraud win for Millennium in 2020.

    Practices

    Complex DisputesLitigationIntellectual PropertyLife Sciences

    Professionals in the Practice Area

    View All
    • John Ruskusky

      Partner / Practice Group Leader, Complex Disputes / Leader, Medical Device, Pharmaceuticals and Diagnostic Health
      • Chicago
      • Office:312.977.4460
        Mobile:708.606.8720
      • jtruskusky@nixonpeabody.com
      John Ruskusky
    • Daniel J. Hurteau

      Partner / Deputy Practice Group Leader, Complex Disputes
      • Albany
      • Office:518.427.2652
      • dhurteau@nixonpeabody.com
      Daniel J. Hurteau
    • Joseph J. Ortego

      Partner / Diversity Partner / Chair, NP Trial® / Leader, Aviation
      • New York
      • Office:212.940.3045
      • jortego@nixonpeabody.com
      Joseph J. Ortego
    • Carolyn G. Nussbaum

      Partner
      • Rochester
      • Office:585.263.1558
        Mobile:585.766.1480
      • cnussbaum@nixonpeabody.com
      Carolyn G. Nussbaum
    • Christopher M. Mason

      Partner / Deputy Leader, Class Actions and Aggregate Litigation / Leader, Arbitration Team
      • New York
      • Office:212.940.3017
      • cmason@nixonpeabody.com
      Christopher M. Mason
    View All

    Insights And Happenings

    • Press Release

      Nixon Peabody adds Los Angeles Intellectual Property counsel, continuing West Coast expansion

      July 9, 2021
    • Press Release

      Nixon Peabody and several of its IP attorneys recognized by IAM Patent 1000 as leaders in their field

      July 8, 2021
    • Press Release

      First Circuit affirms decision recognizing Reuben Klamer as The Game of Life author and copyright owner

      June 28, 2021

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL